المؤلفون: Wang S; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, China., Liu Y; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, China., Liang Y; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, China., Xi Y; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, China., Zhai Y; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, China., Lee D; Department of Plant Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, South Korea., Xu J; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, China; State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. Electronic address: xujing611@nankai.edu.cn., Guo Y; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, China. Electronic address: victgyq@nankai.edu.cn.

المصدر: Chinese journal of natural medicines [Chin J Nat Med] 2024 Sep; Vol. 22 (9), pp. 842-853.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Science Press Country of Publication: China NLM ID: 101504416 Publication Model: Print Cited Medium: Internet ISSN: 1875-5364 (Electronic) Linking ISSN: 18755364 NLM ISO Abbreviation: Chin J Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Vascular Endothelial Growth Factor Receptor-2*/antagonists & inhibitors , Vascular Endothelial Growth Factor Receptor-2*/metabolism , Zebrafish* , Angiogenesis Inhibitors*/pharmacology , Angiogenesis Inhibitors*/chemistry , Angiogenesis Inhibitors*/isolation & purification , Casearia*/chemistry, Animals ; Humans ; Molecular Structure ; Neovascularization, Pathologic/drug therapy ; Antineoplastic Agents, Phytogenic/pharmacology ; Antineoplastic Agents, Phytogenic/chemistry ; Diterpenes/pharmacology ; Diterpenes/chemistry ; Diterpenes/isolation & purification ; Cell Line, Tumor ; Diterpenes, Clerodane/pharmacology ; Diterpenes, Clerodane/chemistry ; Angiogenesis

المؤلفون: Wang X; Department of Chinese Medicine Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China,Chengdu, China; Chengdu University of Traditional Chinese Medicine, Chengdu, China., Liu E; Chengdu University of Traditional Chinese Medicine, Chengdu, China., Hou C; Jiangsu Province Hospital of Traditional Chinese Medicine Chongqing Hospital, Chongqing, China., Wang Y; Jiangsu Province Hospital of Traditional Chinese Medicine Chongqing Hospital, Chongqing, China., Zhao Y; Department of Dermatology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China., Guo J; Dermatological Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Electronic address: guojing66@cdutcm.edu.cn., Li M; Special Needs Outpatient Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Electronic address: 617106382@qq.com.

المصدر: Fitoterapia [Fitoterapia] 2024 Sep; Vol. 177, pp. 106100. Date of Electronic Publication: 2024 Jul 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 16930290R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-6971 (Electronic) Linking ISSN: 0367326X NLM ISO Abbreviation: Fitoterapia Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Melanoma*/blood supply , Biological Products*/pharmacology , Neovascularization, Pathologic*/drug therapy , Skin Neoplasms*/drug therapy , Angiogenesis Inhibitors*/pharmacology, Humans ; Animals ; Antineoplastic Agents, Phytogenic/pharmacology ; Angiogenesis

المؤلفون: Liu D; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands; Amsterdam UMC location University of Amsterdam, Department of Medical Oncology, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands., Guo L; Amsterdam UMC location University of Amsterdam, Department Experimental Immunology, Amsterdam Infection and Immunity Center, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands., Waasdorp C; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands., Meijer SL; Amsterdam UMC Location University of Amsterdam, Department of Pathology, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands., Bootsma S; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands; Amsterdam UMC location University of Amsterdam, Department of Medical Oncology, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands., Oyarce C; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands., Bijlsma MF; Amsterdam UMC Location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands., van Laarhoven HWM; Amsterdam UMC location University of Amsterdam, Department of Medical Oncology, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands. Electronic address: h.vanlaarhoven@amsterdamumc.nl.

المصدر: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Sep; Vol. 178, pp. 117261. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: Paclitaxel*/pharmacology , Paclitaxel*/administration & dosage , Paclitaxel*/therapeutic use , Hyaluronoglucosaminidase*/administration & dosage , Esophageal Neoplasms*/drug therapy , Esophageal Neoplasms*/pathology , Angiogenesis Inhibitors*/pharmacology , Angiogenesis Inhibitors*/administration & dosage , Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/pathology , Xenograft Model Antitumor Assays* , Albumins*/pharmacology , Albumins*/administration & dosage , Neovascularization, Pathologic*/drug therapy , Neovascularization, Pathologic*/pathology, Animals ; Humans ; Mice ; Hyaluronic Acid/pharmacology ; Mice, Nude ; Female ; Angiogenesis ; Antibodies, Monoclonal

المؤلفون: Albini A; European Institute of Oncologi IEO, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Noonan DM; Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.; IRCCS MultiMedica, Milan, Italy., Corradino P; European Institute of Oncologi IEO, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Magnoni F; European Institute of Oncologi IEO, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Corso G; European Institute of Oncologi IEO, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

المصدر: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2024 Jul 02; Vol. 17 (7), pp. 289-303.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101479409 Publication Model: Print Cited Medium: Internet ISSN: 1940-6215 (Electronic) Linking ISSN: 19406215 NLM ISO Abbreviation: Cancer Prev Res (Phila) Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Neoplasms*/prevention & control , Neoplasms*/pathology , Neovascularization, Pathologic*/drug therapy , Neovascularization, Pathologic*/prevention & control , Neovascularization, Pathologic*/pathology , Angiogenesis Inhibitors*/therapeutic use , Angiogenesis Inhibitors*/pharmacology, Humans ; Animals ; Angiogenesis

المؤلفون: Dou M; Department of Biological Sciences, Faculty of Health Sciences, University of Macau, Macau, PR China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, PR China; Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, PR China; Proteomics, Metabolomics and Drug development core facility, Faculty of Health Sciences, University of Macau, Macau SAR, China., Zhu D; Department of Biological Sciences, Faculty of Health Sciences, University of Macau, Macau, PR China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, PR China; Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, PR China; Cancer Center, Faculty of Health Sciences, University of Macau, Macau, PR China., Cui G; Bioengineering department, Zunyi Medical college, Zhuhai, Guangdong, Province, PR China., Li H; Guang' amen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China., Di L; Department of Biological Sciences, Faculty of Health Sciences, University of Macau, Macau, PR China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, PR China; Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, PR China; Cancer Center, Faculty of Health Sciences, University of Macau, Macau, PR China. Electronic address: lijundi@umac.mo., Wang L; Department of Biological Sciences, Faculty of Health Sciences, University of Macau, Macau, PR China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, PR China; Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, PR China; Proteomics, Metabolomics and Drug development core facility, Faculty of Health Sciences, University of Macau, Macau SAR, China. Electronic address: liwang@umac.mo.

المصدر: Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2024 Jul; Vol. 129, pp. 155666. Date of Electronic Publication: 2024 Apr 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Urban & Fischer Verlag Country of Publication: Germany NLM ID: 9438794 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-095X (Electronic) Linking ISSN: 09447113 NLM ISO Abbreviation: Phytomedicine Subsets: MEDLINE

مواضيع طبية MeSH: Euphorbia*/chemistry , Hemangioendothelioma*/drug therapy , Reactive Oxygen Species*/metabolism , Angiogenesis Inhibitors*/pharmacology , Apoptosis*/drug effects , Cell Proliferation*/drug effects , Plant Extracts*/pharmacology , Antineoplastic Agents, Phytogenic*/pharmacology, Animals ; Humans ; Mice ; Cell Line, Tumor ; Melanoma/drug therapy ; Plant Leaves/chemistry ; Melanoma, Experimental/drug therapy ; Neovascularization, Pathologic/drug therapy ; Mice, Inbred C57BL ; Male ; Angiogenesis

المؤلفون: Jasim SA; Medical Laboratory Techniques Department, Al-Maarif University College, Anbar, Iraq., Farber IM; Department of children's diseases of the F. Filatov clinical institute of children's health, I. M. Sechenov First Moscow State Medical University of Health of Russian Federation (Sechenov University), Moscow, Russia., Noraldeen SAM; Department of Oncology and Metabolism, University of Tabuk, Tabuk, Saudi Arabia., Bansal P; Department of Biotechnology and Genetics, Jain (Deemed-to-be) University, Bengaluru, Karnataka 560069, India; Department of Allied Healthcare and Sciences, Vivekananda Global University, Jaipur, Rajasthan 303012, India., Alsaab HO; Department of Pharmaceutics and Pharmaceutical Technology, Taif University, Taif 21944, Saudi Arabia., Abdullaev B; Research Department of Biotechnology, New Uzbekistan University, Mustaqillik Avenue 54, Tashkent 100007, Uzbekistan; Department of Oncology, School of Medicine, Central Asian University, Milliy Bog Street 264, Tashkent 111221, Uzbekistan.. Electronic address: ayntraxt@gmail.com., Alkhafaji AT; Cardiology Department, College of Medicine, Al-Ayen University, Thi-Qar, Iraq., Alawadi AH; College of Technical Engineering, the Islamic University, Najaf, Iraq; College of Technical Engineering, the Islamic University of Al Diwaniyah, Qadisiyyah, Iraq; College of Technical Engineering, the Islamic University of Babylon, Babylon, Iraq., Hamzah HF; Department of Medical Laboratories Technology, AL-Nisour University College, Baghdad, Iraq., Mohammed BA; Department of Technical Engineering, Al-Hadi University College, Baghdad 10011, Iraq.

المصدر: Microvascular research [Microvasc Res] 2024 Jul; Vol. 154, pp. 104691. Date of Electronic Publication: 2024 May 03.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0165035 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9319 (Electronic) Linking ISSN: 00262862 NLM ISO Abbreviation: Microvasc Res Subsets: MEDLINE

مواضيع طبية MeSH: Neovascularization, Pathologic* , Neoplasms*/therapy , Neoplasms*/immunology , Neoplasms*/blood supply , Neoplasms*/drug therapy , Immunotherapy* , Angiogenesis Inhibitors*, Humans ; Animals ; Tumor Microenvironment ; Nanomedicine ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/therapeutic use ; Angiogenesis

المؤلفون: Guo Z; Department of Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China., Jing X; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17177, Sweden., Sun X; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17177, Sweden.; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vison and Brain Health), School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China., Sun S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17177, Sweden.; Cancer Institute, the First Clinical Medical College, Xuzhou Medical University, Xuzhou, Jiangsu 221000, China., Yang Y; Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China., Cao Y; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 17177, Sweden.

المصدر: Chinese medical journal [Chin Med J (Engl)] 2024 Sep 05; Vol. 137 (17), pp. 2043-2051. Date of Electronic Publication: 2024 Jul 25.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Chinese Medical Association ; produced by Wolters Kluwer Country of Publication: China NLM ID: 7513795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2542-5641 (Electronic) Linking ISSN: 03666999 NLM ISO Abbreviation: Chin Med J (Engl) Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors*/therapeutic use , Neovascularization, Pathologic*/drug therapy , Neoplasms*/drug therapy , Neoplasms*/blood supply, Humans ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Vascular Endothelial Growth Factor A/metabolism ; Bevacizumab/therapeutic use ; Signal Transduction/drug effects ; Angiogenesis

المؤلفون: Lusardi M; Department of Pharmacy, Section of Medicinal Chemistry, University of Genoa, Viale Benedetto XV 3, I-16132, Genova, Italy., Belvedere R; Department of Pharmacy, University of Salerno, Viale Giovanni Paolo II, 84084, Salerno, Italy., Petrella A; Department of Pharmacy, University of Salerno, Viale Giovanni Paolo II, 84084, Salerno, Italy., Iervasi E; IRCCS Ospedale Policlinico San Martino, Proteomics and Mass Spectrometry Unit, Largo. R. Benzi, 10, 16132, Genova, Italy., Ponassi M; IRCCS Ospedale Policlinico San Martino, Proteomics and Mass Spectrometry Unit, Largo. R. Benzi, 10, 16132, Genova, Italy., Brullo C; Department of Pharmacy, Section of Medicinal Chemistry, University of Genoa, Viale Benedetto XV 3, I-16132, Genova, Italy., Spallarossa A; Department of Pharmacy, Section of Medicinal Chemistry, University of Genoa, Viale Benedetto XV 3, I-16132, Genova, Italy. Electronic address: andrea.spallarossa@unige.it.

المصدر: European journal of medicinal chemistry [Eur J Med Chem] 2024 Oct 05; Vol. 276, pp. 116715. Date of Electronic Publication: 2024 Jul 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Pyrazoles*/pharmacology , Pyrazoles*/chemistry , Pyrazoles*/chemical synthesis , Calcium*/metabolism , Human Umbilical Vein Endothelial Cells*/drug effects , Angiogenesis Inhibitors*/pharmacology , Angiogenesis Inhibitors*/chemical synthesis , Angiogenesis Inhibitors*/chemistry , Molecular Docking Simulation*, Humans ; Structure-Activity Relationship ; Molecular Structure ; Calreticulin/metabolism ; Drug Screening Assays, Antitumor ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Dose-Response Relationship, Drug ; Neovascularization, Pathologic/drug therapy ; Angiogenesis

المؤلفون: Inglis SS; Van Cleve Cardiac Regenerative Medicine Program, Mayo Clinic, Rochester, Minnesota, USA., Asleh R; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Iyer VN; Department of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA., Schettle SD; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA., Spencer PJ; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA., Villavicencio MA; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA., Rodeheffer RJ; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Kushwaha SS; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Behfar A; Van Cleve Cardiac Regenerative Medicine Program, Mayo Clinic, Rochester, Minnesota, USA.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Rosenbaum AN; Van Cleve Cardiac Regenerative Medicine Program, Mayo Clinic, Rochester, Minnesota, USA.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

المصدر: Artificial organs [Artif Organs] 2024 Jun; Vol. 48 (6), pp. 646-654. Date of Electronic Publication: 2023 Dec 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7802778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1594 (Electronic) Linking ISSN: 0160564X NLM ISO Abbreviation: Artif Organs Subsets: MEDLINE

مواضيع طبية MeSH: Heart-Assist Devices*/adverse effects , Gastrointestinal Hemorrhage*/etiology , Gastrointestinal Hemorrhage*/therapy , Angiogenesis Inhibitors*/therapeutic use , Angiogenesis Inhibitors*/adverse effects , Angiogenesis Inhibitors*/administration & dosage , Pyrimidines*/therapeutic use , Pyrimidines*/adverse effects , Bevacizumab*/therapeutic use , Bevacizumab*/adverse effects , Bevacizumab*/administration & dosage , Sulfonamides*/therapeutic use , Indazoles*/adverse effects , Indazoles*/therapeutic use, Humans ; Male ; Female ; Aged ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; Angiogenesis

المؤلفون: Zhong C; Division of Pharmaceutical Sciences, James L Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, USA. Electronic address: zhongch@mail.uc.edu., Shi Z; Division of Pharmaceutical Sciences, James L Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, USA., Binzel DW; Center for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA., Jin K; Center for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA., Li X; Center for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA., Guo P; Center for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA; Dorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University, Columbus, OH 43210, USA., Li SK; Division of Pharmaceutical Sciences, James L Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, USA.

المصدر: International journal of pharmaceutics [Int J Pharm] 2024 May 25; Vol. 657, pp. 124151. Date of Electronic Publication: 2024 Apr 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Nanoparticles*/chemistry , Angiogenesis Inhibitors*/administration & dosage , Angiogenesis Inhibitors*/pharmacology , Angiogenesis Inhibitors*/chemistry , Vascular Endothelial Growth Factor A* , RNA*/administration & dosage, Animals ; Aptamers, Nucleotide/administration & dosage ; Aptamers, Nucleotide/chemistry ; Humans ; Angiopoietin-2 ; Male ; Mice ; Conjunctiva/metabolism ; Injections, Intraocular ; Cell Proliferation/drug effects ; Neovascularization, Pathologic/drug therapy ; Human Umbilical Vein Endothelial Cells/drug effects ; Retina/metabolism ; Retina/drug effects ; Drug Delivery Systems/methods ; Mice, Inbred C57BL ; Angiogenesis